MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Follesa, P.
Right arrow Articles by Mocchetti, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Follesa, P.
Right arrow Articles by Mocchetti, I.

Regulation of basic fibroblast growth factor and nerve growth factor mRNA by beta-adrenergic receptor activation and adrenal steroids in rat central nervous system

P Follesa and I Mocchetti

Department of Anatomy and Cell Biology, Georgetown University, School of Medicine, Washington, D.C. 20007.

Basic fibroblast growth factor (bFGF) and nerve growth factor (NGF) are two neurotrophic factors that play a role in neuronal maintenance and repair. The identification and characterization of mechanisms regulating neurotrophic factor availability in the central nervous system are vital to the development of therapeutic tools for prevention of neuronal degeneration. The lipophilic beta-adrenergic receptor (BAR) agonist clenbuterol was used to assess whether activation of central BAR changes the levels of NGF and bFGF mRNA. Within 5 hr, clenbuterol (10 mg/kg, intraperitoneally) elicited a 2-3-fold increase in bFGF and NGF mRNA content in rat cerebral cortex. The induction of bFGF and NGF mRNA expression showed anatomical specificity. Among the various brain areas examined, bFGF mRNA levels were increased in the cerebral cortex, hippocampus, and cerebellum, whereas induction of NGF mRNA was observed only in the cerebral cortex. Isoproterenol, a BAR agonist that does not cross the blood-brain barrier, also elicited a 2-3-fold increase in bFGF and NGF mRNA in the cerebral cortex. Propranolol (5 mg/kg, intraperitoneally), a lipophilic BAR antagonist, blocked the induction of NGF and bFGF mRNA mediated by either isoproterenol or clenbuterol, whereas nadolol (5 mg/kg, intraperitoneally), a BAR antagonist that does not cross the blood-brain barrier, blocked only the effect of isoproterenol. Therefore, activation of both central and peripheral BAR play a role in the regulation of bFGF and NGF mRNA expression. Moreover, in adrenalectomized rats, isoproterenol failed to increase bFGF and NGF mRNA, whereas clenbuterol elicited a 2-fold increase in bFGF mRNA in the cortex and hippocampus. Our data suggest that both adrenal steroids and noradrenaline might regulate the availability of selective neurotrophic factors in the adult central nervous system.

Volume 43, Issue 2, pp. 132-138, 02/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
I. S. Hairston, C. Peyron, D. P. Denning, N. F. Ruby, J. Flores, R. M. Sapolsky, H. C. Heller, and B. F. O'Hara
Sleep Deprivation Effects on Growth Factor Expression in Neonatal Rats: A Potential Role for BDNF in the Mediation of Delta Power
J Neurophysiol, April 1, 2004; 91(4): 1586 - 1595.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. C. Hansson, W. Sommer, R. Rimondini, B. Andbjer, I. Stromberg, and K. Fuxe
c-fos Reduces Corticosterone-Mediated Effects on Neurotrophic Factor Expression in the Rat Hippocampal CA1 Region
J. Neurosci., July 9, 2003; 23(14): 6013 - 6022.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Mallei, B. Shi, and I. Mocchetti
Antidepressant Treatments Induce the Expression of Basic Fibroblast Growth Factor in Cortical and Hippocampal Neurons
Mol. Pharmacol., May 1, 2002; 61(5): 1017 - 1024.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Marini, S. J. Rabin, R. H. Lipsky, and I. Mocchetti
Activity-dependent Release of Brain-derived Neurotrophic Factor Underlies the Neuroprotective Effect of N-Methyl-D-aspartate
J. Biol. Chem., November 6, 1998; 273(45): 29394 - 29399.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. M. Colangelo, P. F. Johnson, and I. Mocchetti
beta -Adrenergic receptor-induced activation of nerve growth factor gene transcription in rat cerebral cortex involves CCAAT/enhancer-binding protein delta
PNAS, September 1, 1998; 95(18): 10920 - 10925.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. S. F. Clarke, M. M. Bamman, and D. L. Feeback
Bed rest decreases mechanically induced myofiber wounding and consequent wound-mediated FGF release
J Appl Physiol, August 1, 1998; 85(2): 593 - 600.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Fornai, M. G. Alessandrì, M. T. Torracca, L. Bassi, and G. U. Corsini
Effects of Noradrenergic Lesions on MPTP/MPP+ Kinetics and MPTP-Induced Nigrostriatal Dopamine Depletions
J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 100 - 107.
[Abstract]


Home page
J. Neurosci.Home page
R. Wen, T. Cheng, Y. Li, W. Cao, and R. H. Steinberg
alpha 2-Adrenergic Agonists Induce Basic Fibroblast Growth Factor Expression in Photoreceptors In Vivo and Ameliorate Light Damage
J. Neurosci., October 1, 1996; 16(19): 5986 - 5992.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics